This initial selection encompassed well-established predictors of breast cancer recurrence such as tumor grade, HER2, ER, PR, menopausal status, tumor size, lymph node involvement, Histological Type, and Tumor Location. This evidence concerns the gene ERBB2 and breast carcinoma.